Sulbutiamine - Revision history

Fire: Marked this version for translation

2024-04-03T02:00:39Z

Marked this version for translation

← Older revision		Revision as of 11:00, 3 April 2024
Line 1:		Line 1:
	<languages />		<languages />
	<translate>		<translate>
			<!--T:1-->
	{{short description\|Chemical compound}}		{{short description\|Chemical compound}}
	{{Drugbox		{{Drugbox
Line 12:		Line 13:
	\| alt2 = Space-filling model of the sulbutiamine molecule		\| alt2 = Space-filling model of the sulbutiamine molecule

			<!--T:2-->
	<!--Clinical data-->		<!--Clinical data-->
	\| tradename = Arcalion, Enerion		\| tradename = Arcalion, Enerion
Line 17:		Line 19:
	\| routes_of_administration = Oral		\| routes_of_administration = Oral

			<!--T:3-->
	<!--Pharmacokinetic data-->		<!--Pharmacokinetic data-->
	\| elimination_half-life = 5 hours		\| elimination_half-life = 5 hours
	\| excretion = [[Kidney\|Renal]]		\| excretion = [[Kidney\|Renal]]

			<!--T:4-->
	<!--Identifiers-->		<!--Identifiers-->
	\| CAS_number_Ref = {{cascite\|changed\|??}}		\| CAS_number_Ref = {{cascite\|changed\|??}}
Line 35:		Line 39:
	\| KEGG = D01319		\| KEGG = D01319

			<!--T:5-->
	<!--Chemical data-->		<!--Chemical data-->
	\| C=32 \| H=46 \| N=8 \| O=6 \| S=2		\| C=32 \| H=46 \| N=8 \| O=6 \| S=2
Line 45:		Line 50:
	}}		}}

			<!--T:6-->
	'''Sulbutiamine''' (brand names '''Arcalion''', '''Enerion''') is a synthetic derivative of [[thiamine]] (vitamin B<sub>1</sub>). In France, it is used to treat symptoms of weakness or fatigue. It is also sold as a dietary supplement. Sulbutiamine was discovered in Japan as part of an effort to develop useful thiamine derivatives.		'''Sulbutiamine''' (brand names '''Arcalion''', '''Enerion''') is a synthetic derivative of [[thiamine]] (vitamin B<sub>1</sub>). In France, it is used to treat symptoms of weakness or fatigue. It is also sold as a dietary supplement. Sulbutiamine was discovered in Japan as part of an effort to develop useful thiamine derivatives.

	==Medical use==		==Medical use== <!--T:7-->
	Sulbutiamine is used to treat [[asthenia]] (symptoms of fatigue or weakness), though is not clear if it is effective in alleviating tiredness. It is also used to treat thiamine deficiency and poor concentration. Being a potent [[cholinergic]] [[anxiolytic]] , Sulbutiamine is a popular [[nootropic]], with users reporting enhanced memory, focus and improved mood and motivation. Endurance athletes may use it to try to enhance their performance.		Sulbutiamine is used to treat [[asthenia]] (symptoms of fatigue or weakness), though is not clear if it is effective in alleviating tiredness. It is also used to treat thiamine deficiency and poor concentration. Being a potent [[cholinergic]] [[anxiolytic]] , Sulbutiamine is a popular [[nootropic]], with users reporting enhanced memory, focus and improved mood and motivation. Endurance athletes may use it to try to enhance their performance.

	==Adverse effects==		==Adverse effects== <!--T:8-->
	Adverse effects found in clinical trials are usually limited to headache and gastrointestinal discomfort when high doses are used. While daily use can result in tolerance and paradoxical drowsiness, increasing the dose is strongly discouraged and side effects can include diarrhea, bladder infections, bronchitis, back pain, abdominal pain, insomnia, constipation, gastroenteritis, headache, vertigo, and sore throat.		Adverse effects found in clinical trials are usually limited to headache and gastrointestinal discomfort when high doses are used. While daily use can result in tolerance and paradoxical drowsiness, increasing the dose is strongly discouraged and side effects can include diarrhea, bladder infections, bronchitis, back pain, abdominal pain, insomnia, constipation, gastroenteritis, headache, vertigo, and sore throat.

	==History==		==History== <!--T:9-->
	[[File:Thiamin.svg\|left\|thumb\|200px\|Thiamine]]		[[File:Thiamin.svg\|left\|thumb\|200px\|Thiamine]]
	Efforts to develop [[thiamine]] derivatives with better bioavailability than thiamine were conducted in the 1950s, mainly in Japan. These efforts led to the discovery of [[allicin]] (diallyl [[thiosulfinate]]) in garlic, which became a model for [[medicinal chemistry]] efforts to create other thiamine disulfides. The results included sulbutiamine, [[fursultiamine]] (thiamine tetrahydrofurfuryl disulfide) and [[benfotiamine]]. These compounds are hydrophobic, easily pass from the intestines to the bloodstream, and are reduced to thiamine by cysteine or glutathione.		Efforts to develop [[thiamine]] derivatives with better bioavailability than thiamine were conducted in the 1950s, mainly in Japan. These efforts led to the discovery of [[allicin]] (diallyl [[thiosulfinate]]) in garlic, which became a model for [[medicinal chemistry]] efforts to create other thiamine disulfides. The results included sulbutiamine, [[fursultiamine]] (thiamine tetrahydrofurfuryl disulfide) and [[benfotiamine]]. These compounds are hydrophobic, easily pass from the intestines to the bloodstream, and are reduced to thiamine by cysteine or glutathione.

			<!--T:10-->
	It was first marketed in France by Servier in 1973 under the brand name Arcalion. The drug registration went through a validation procedure in France in the 1980s, which found that the use for treatment of fatigue was not supported by data. In January 1989, 100 mg tablet doses were discontinued in favour of 200 mg tablets.		It was first marketed in France by Servier in 1973 under the brand name Arcalion. The drug registration went through a validation procedure in France in the 1980s, which found that the use for treatment of fatigue was not supported by data. In January 1989, 100 mg tablet doses were discontinued in favour of 200 mg tablets.

	==Research==		==Research== <!--T:11-->
	Because [[thiamine deficiency]] causes problems with memory and other cognitive functions, thiamine and analogs like sulbutiamine have been studied in clinical trials in the 1980s and 1990s for age-associated cognitive decline.		Because [[thiamine deficiency]] causes problems with memory and other cognitive functions, thiamine and analogs like sulbutiamine have been studied in clinical trials in the 1980s and 1990s for age-associated cognitive decline.

			<!--T:12-->
	Sulbutiamine has been explored in clinical trials as a potential treatment for [[chronic fatigue syndrome]]. Studies have also been undertaken to		Sulbutiamine has been explored in clinical trials as a potential treatment for [[chronic fatigue syndrome]]. Studies have also been undertaken to
	assess its impact on reversing age-related changes in the circadian system.		assess its impact on reversing age-related changes in the circadian system.

			<!--T:13-->
	The pharmacology of sulbutiamine has been studied in various mice and rats; as of 2014 it appeared that sulbutiamine might be more effective in raising thiamine phosphate levels in the brain than benfotiamine and fursultiamine, but this has not been fully verified. University of Oxford studies indicate that it helps prevent [[apoptotic]] cell death, caused by [[trophic factor]] deprivation, in retinal [[ganglion]] cells.		The pharmacology of sulbutiamine has been studied in various mice and rats; as of 2014 it appeared that sulbutiamine might be more effective in raising thiamine phosphate levels in the brain than benfotiamine and fursultiamine, but this has not been fully verified. University of Oxford studies indicate that it helps prevent [[apoptotic]] cell death, caused by [[trophic factor]] deprivation, in retinal [[ganglion]] cells.

			<!--T:14-->
	In an uncontrollled clinical trial, sulbutiamine was reported to be effective in reducing fatigue in patients with multiple sclerosis.		In an uncontrollled clinical trial, sulbutiamine was reported to be effective in reducing fatigue in patients with multiple sclerosis.

	== See also ==		== See also == <!--T:15-->
	* [[Vitamin B1 analogue\|Vitamin B<sub>1</sub> analogue]]		* [[Vitamin B1 analogue\|Vitamin B<sub>1</sub> analogue]]
	* [[Pyritinol]]		* [[Pyritinol]]


			<!--T:16-->
	{{Vitamins}}		{{Vitamins}}

			<!--T:17-->
	{{二次利用\|date=23 March 2024}}		{{二次利用\|date=23 March 2024}}
	[[Category:Aromatic amines]]		[[Category:Aromatic amines]]

Fire at 01:56, 3 April 2024

2024-04-03T01:56:24Z

← Older revision		Revision as of 10:56, 3 April 2024
Line 1:		Line 1:
	<~~labnguages~~ />		<languages />
	<translate>		<translate>
	{{short description\|Chemical compound}}		{{short description\|Chemical compound}}

Fire at 01:56, 3 April 2024

2024-04-03T01:56:15Z

← Older revision		Revision as of 10:56, 3 April 2024
Line 2:		Line 2:
	<translate>		<translate>
	{{short description\|Chemical compound}}		{{short description\|Chemical compound}}
	~~{{cs1 config\|name-list-style=vanc}}~~
	{{Drugbox		{{Drugbox
	\| Verifiedfields = changed		\| Verifiedfields = changed

Fire: Created page with " {{short description|Chemical compound}} {{cs1 config|name-list-style=vanc}} {{Drugbox | Verifiedfields = changed | verifiedrevid = 470472774 | IUPAC_name = [4-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-3-[2-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-5-(2-methylpropanoyloxy)pent-2-en-3-yl]disulfanyl-pent-3-enyl] 2-methylpropanoate | image = sulbutiamine.svg | alt = Skeletal formula of sulbutiamine | width = 240 | image2 =..."

2024-04-03T01:56:03Z

Created page with "<labnguages /> <translate> {{short description|Chemical compound}} {{cs1 config|name-list-style=vanc}} {{Drugbox | Verifiedfields = changed | verifiedrevid = 470472774 | IUPAC_name = [4-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-3-[2-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-5-(2-methylpropanoyloxy)pent-2-en-3-yl]disulfanyl-pent-3-enyl] 2-methylpropanoate | image = sulbutiamine.svg | alt = Skeletal formula of sulbutiamine | width = 240 | image2 =..."

New page

<labnguages />
<translate>
{{short description|Chemical compound}}
{{cs1 config|name-list-style=vanc}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 470472774
| IUPAC_name = [4-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-3-[2-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-amino]-5-(2-methylpropanoyloxy)pent-2-en-3-yl]disulfanyl-pent-3-enyl] 2-methylpropanoate
| image = sulbutiamine.svg
| alt = Skeletal formula of sulbutiamine
| width = 240
| image2 = Sulbutiamine 3D spacefill.png
| alt2 = Space-filling model of the sulbutiamine molecule


| tradename = Arcalion, Enerion
| Drugs.com = {{drugs.com|international|sulbutiamine}}
| routes_of_administration = Oral


| elimination_half-life = 5 hours
| excretion = [[Kidney|Renal]]


| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 3286-46-2
| ATC_prefix = A11
| ATC_suffix = DA02
| PubChem = 71124
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 16736830
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 42NCM1BW43
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01319


| C=32 | H=46 | N=8 | O=6 | S=2
| smiles = Nc2nc(C)ncc2CN(C=O)C(/C)=C(/CCOC(=O)C(C)C)SSC(/CCOC(=O)C(C)C)=C(/C)N(C=O)Cc1cnc(C)nc1N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C32H46N8O6S2/c1-19(2)31(43)45-11-9-27(21(5)39(17-41)15-25-13-35-23(7)37-29(25)33)47-48-28(10-12-46-32(44)20(3)4)22(6)40(18-42)16-26-14-36-24(8)38-30(26)34/h13-14,17-20H,9-12,15-16H2,1-8H3,(H2,33,35,37)(H2,34,36,38)/b27-21-,28-22-
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CKHJPWQVLKHBIH-ZDSKVHJSSA-N
| synonyms =
}}

'''Sulbutiamine''' (brand names '''Arcalion''', '''Enerion''') is a synthetic derivative of [[thiamine]] (vitamin B<sub>1</sub>). In France, it is used to treat symptoms of weakness or fatigue. It is also sold as a dietary supplement. Sulbutiamine was discovered in Japan as part of an effort to develop useful thiamine derivatives.

==Medical use==
Sulbutiamine is used to treat [[asthenia]] (symptoms of fatigue or weakness), though is not clear if it is effective in alleviating tiredness. It is also used to treat thiamine deficiency and poor concentration. Being a potent [[cholinergic]] [[anxiolytic]] , Sulbutiamine is a popular [[nootropic]], with users reporting enhanced memory, focus and improved mood and motivation. Endurance athletes may use it to try to enhance their performance.

==Adverse effects==
Adverse effects found in clinical trials are usually limited to headache and gastrointestinal discomfort when high doses are used. While daily use can result in tolerance and paradoxical drowsiness, increasing the dose is strongly discouraged and side effects can include diarrhea, bladder infections, bronchitis, back pain, abdominal pain, insomnia, constipation, gastroenteritis, headache, vertigo, and sore throat.

==History==
[[File:Thiamin.svg|left|thumb|200px|Thiamine]]
Efforts to develop [[thiamine]] derivatives with better bioavailability than thiamine were conducted in the 1950s, mainly in Japan. These efforts led to the discovery of [[allicin]] (diallyl [[thiosulfinate]]) in garlic, which became a model for [[medicinal chemistry]] efforts to create other thiamine disulfides. The results included sulbutiamine, [[fursultiamine]] (thiamine tetrahydrofurfuryl disulfide) and [[benfotiamine]]. These compounds are hydrophobic, easily pass from the intestines to the bloodstream, and are reduced to thiamine by cysteine or glutathione.

It was first marketed in France by Servier in 1973 under the brand name Arcalion. The drug registration went through a validation procedure in France in the 1980s, which found that the use for treatment of fatigue was not supported by data. In January 1989, 100 mg tablet doses were discontinued in favour of 200 mg tablets.

==Research==
Because [[thiamine deficiency]] causes problems with memory and other cognitive functions, thiamine and analogs like sulbutiamine have been studied in clinical trials in the 1980s and 1990s for age-associated cognitive decline.

Sulbutiamine has been explored in clinical trials as a potential treatment for [[chronic fatigue syndrome]]. Studies have also been undertaken to
assess its impact on reversing age-related changes in the circadian system.

The pharmacology of sulbutiamine has been studied in various mice and rats; as of 2014 it appeared that sulbutiamine might be more effective in raising thiamine phosphate levels in the brain than benfotiamine and fursultiamine, but this has not been fully verified. University of Oxford studies indicate that it helps prevent [[apoptotic]] cell death, caused by [[trophic factor]] deprivation, in retinal [[ganglion]] cells.

In an uncontrollled clinical trial, sulbutiamine was reported to be effective in reducing fatigue in patients with multiple sclerosis.

== See also ==
* [[Vitamin B1 analogue|Vitamin B<sub>1</sub> analogue]]
* [[Pyritinol]]

{{Vitamins}}

{{二次利用|date=23 March 2024}}
[[Category:Aromatic amines]]
[[Category:Formamides]]
[[Category:Isobutyrate esters]]
[[Category:Nootropics]]
[[Category:Organic disulfides]]
[[Category:Pyrimidines]]
[[Category:Thiamine]]
</translate>